Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | November 21, 2024 | November 25, 2024 |
| HCA Healthcare, Inc.HCA · Entity 2929 | Director | April 28, 2026 | April 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date November 21, 2024 · Filed November 25, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,169 |
Reported balance
After 2024-11-21 transaction · row 1
1 source rowRow 1 · 2024-11-21 · Grant · Acquired 2,331 · Balance 34,169 F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. |
| Share CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,635.0665 |
Reported balance
Holding disclosure · report date 2024-11-21 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 3,635.0665 F2: Consists of deferred stock compensation payable pursuant to Reporting Person's election. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2: Consists of deferred stock compensation payable pursuant to Reporting Person's election.
HCA Healthcare, Inc.
Report date April 28, 2026 · Filed April 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,910 |
Reported balance
After 2026-04-28 transaction · row 1
1 source rowRow 1 · 2026-04-28 · Grant · Acquired 509 · Balance 21,910 F1: Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2026 Filed Apr 30, 2026 16:59 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-197746 · ownership.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,910 F1 · kind: Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| April 29, 2025 Filed May 1, 2025 18:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 645 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-062120 · ownership.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,401 F1 · kind: Represents common stock underlying 645 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 22:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,331 | $57.10 | $133,100.10 |
DisclosureSEC source: 0001127602-24-027998 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,169 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,314 | $57.52 | $133,101.28 |
DisclosureSEC source: 0001127602-24-015898 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,838 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| April 29, 2024 Filed May 1, 2024 18:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-005447 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,756 F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,925 | $69.13 | $133,075.25 |
DisclosureSEC source: 0001127602-23-027827 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,524 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,437 | $69.31 | $99,598.47 |
DisclosureSEC source: 0001127602-23-016331 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,599 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 16:57 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 663 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025697 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,146 F1 · kind: Represents common stock underlying 663 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2024 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,402 | $94.93 | $133,091.86 |
DisclosureSEC source: 0001127602-22-026169 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,162 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,358 | $97.99 | $133,070.42 |
DisclosureSEC source: 0001127602-22-014462 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,760 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025858 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,483 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,334 | $92.73 | $123,701.82 |
DisclosureSEC source: 0001127602-21-029713 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,402 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,468 | $84.27 | $123,708.36 |
DisclosureSEC source: 0001127602-21-016899 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,068 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029382 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,581 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 22:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,836 | $66.35 | $121,818.60 |
DisclosureSEC source: 0001127602-20-029744 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,600 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,955 | $62.31 | $121,816.05 |
DisclosureSEC source: 0001127602-20-016770 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,764 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027343 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,700 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the Issuer's 2021 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,626 | $74.92 | $121,819.92 |
DisclosureSEC source: 0001127602-19-033576 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,339 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,330 | $52.30 | $121,859.00 |
DisclosureSEC source: 0001127602-19-019162 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,713 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 01, 2019 Filed May 3, 2019 17:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 1,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027444 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,032 F1 · kind: Represents common stock underlying 1,410 restricted share units which shall vest on the sooner of the date of the Issuer's 2020 annual shareholders' meeting or the first anniversary of the grant date. F2 · balance_after: On May 4, 2018, a Form 4 was filed for the reporting person and due to a computational error, the cumulative amount in column 5 was incorrectly reported as 14,662 instead of 14,622. The amount of securities beneficially owned is corrected herein. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,332 | $78.77 | $104,921.64 |
DisclosureSEC source: 0001127602-18-032659 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,383 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,638 | $64.10 | $104,995.80 |
DisclosureSEC source: 0001127602-18-020155 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,051 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 02, 2018 Filed May 4, 2018 17:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 1,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028156 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,662 F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,521 | $68.99 | $104,933.79 |
DisclosureSEC source: 0001127602-17-031764 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,413 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,297 | $80.94 | $104,979.18 |
DisclosureSEC source: 0001127602-17-017942 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,892 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 03, 2017 Filed May 5, 2017 20:17 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 2,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030311 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,832 F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,250 | $83.95 | $104,937.50 |
DisclosureSEC source: 0001127602-16-066172 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,595 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 19, 2016 Filed May 20, 2016 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,040 | $100.95 | $104,988.00 |
DisclosureSEC source: 0001127602-16-052955 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,345 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 210.9069 | $99.57 Strike: $0.00 | $21,000.00 |
DisclosureSEC source: 0001127602-15-030628 · form4.xml · derivative · entry 2 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,223.2012 Underlying: Common Stock · 210.9069 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 843 | $99.57 | $83,937.51 |
DisclosureSEC source: 0001127602-15-030628 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,305 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 07, 2015 Filed May 11, 2015 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 211.3527 | $99.36 Strike: $0.00 | $21,000.00 |
DisclosureSEC source: 0001127602-15-016841 · form4.xml · derivative · entry 2 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,992.5439 Underlying: Common Stock · 211.3527 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 07, 2015 Filed May 11, 2015 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 845 | $99.36 | $83,959.20 |
DisclosureSEC source: 0001127602-15-016841 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,462 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 800 | $87.50 Strike: $0.00 | $70,000.00 |
DisclosureSEC source: 0001127602-14-031475 · form4.xml · derivative · entry 2 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,761.7535 Underlying: Common Stock · 800 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 600 | $87.50 | $52,500.00 |
DisclosureSEC source: 0001127602-14-031475 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,617 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 08, 2014 Filed May 9, 2014 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 922.7524 | $75.86 Strike: $0.00 | $70,000.00 |
DisclosureSEC source: 0001127602-14-016994 · form4.xml · derivative · entry 2 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,948.5036 Underlying: Common Stock · 922.7524 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 08, 2014 Filed May 9, 2014 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 692 | $75.86 | $52,495.12 |
DisclosureSEC source: 0001127602-14-016994 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,017 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 06, 2013 Filed Nov 8, 2013 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,017.6922 | $63.87 Strike: $0.00 | $65,000.00 |
DisclosureSEC source: 0001127602-13-031076 · form4.xml · derivative · entry 2 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,017.6922 Underlying: Common Stock · 1,017.6922 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 06, 2013 Filed Nov 8, 2013 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 763 | $63.87 | $48,732.81 |
DisclosureSEC source: 0001127602-13-031076 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,325 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| September 25, 2013 Filed Sep 27, 2013 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 562 | $57.78 | $32,472.36 |
DisclosureSEC source: 0001127602-13-027940 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562 F1 · shares: Consists of common stock issued as a pro rata portion of the retainer payable for the Reporting Person's 2013 Board service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.